Molecular Partners reports financial results and highlights from Q1 2025 (CHF 3.26, 0.00)
StreetAccount Summary - Trading higher/lower: EU mid-morning
Molecular Partners presents new preclinical data on Radio-DARPin and Switch-DARPin programs at AACR 2025 (CHF 3.42, 0.00)
StreetAccount Sector Summary - Healthcare Post-Market
StreetAccount Sector Summary - Healthcare Pre-Market
Clear Street initiates BEAM, MOLN
LifeSci Capital initiates IMNM, MOLN, TARA, and ZYME
Powered by FactSet Research Systems Inc.